Evidence map›Paper›PMID 36636123›Full record

ReviewAmerican journal of preventive cardiology2023

Leveling the playing field: The utility of coronary artery calcium scoring in cardiovascular risk stratification in South Asians.

Anandita Agarwala, Jaideep Patel, Michael Blaha, Miguel Cainzos-Achirica, Khurram Nasir, Matthew Budoff

Open access · goldAbstract readReview
In one paragraph

Review in American journal of preventive cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Anandita AgarwalaCenter for Cardiovascular Disease Prevention, Cardiovascular Division, Baylor Scott and White Health Heart Hospital Baylor Plano, Plano, TX, United States.
Jaideep PatelCiccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States.
Michael BlahaCiccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, United States.
Miguel Cainzos-AchiricaJohns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, South Asian Cardiovascular Health Initiative (SACHI), Baltimore, MD, United States.
Khurram NasirDivision of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Center for Outcomes Research, Houston Methodist, Houston, TX, United States.
Matthew BudoffUCLA, School of Medicine, Los Angeles Biomedical Research Institute, Torrance, CA, United States.
Greater Baltimore Medical Center · USHeart Hospital Baylor Plano · USHospital del Mar Research Institute · ESHouston Methodist · USThe Lundquist Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

South Asian (SA) individuals, particularly those that reside in the United States and other Westernized countries, are at an elevated risk for ASCVD and mortality related to ASCVD. The 2018 ACC/AHA/Multi-society Cholesterol guideline listed SA as a high-risk ethnicity, underscoring the importance of treating modifiable risk factors to reduce ASCVD burden. Coronary artery calcium (CAC), a highly specific marker of subclinical atherosclerosis, may be a useful test to improve risk stratification among SA individuals. CAC testing is a cost-effective, highly reproducible, and specific marker of subclinical atherosclerosis, shown to improve ASCVD risk assessment across all racial/ethnic groups, thereby serving as a guide for initiating or deferring preventive therapies. In this White Paper we will discuss the use of CAC scoring to optimize risk stratification and delivery of preventive therapies to individuals of SA ethnicity.

Indexed as

Coronary artery calciumLipidPreventionSouth AsianStatin

Identifiers

PMID36636123
PMCPMC9830106
OpenAlexW4313421061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.